Literature DB >> 27283753

Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

L I Petrella1,2, Y Cai3,4,5,6,7, J V Sereno1,2, S I Gonçalves1,2, A J Silva3,4,5,6,7, M Castelo-Branco8,9.   

Abstract

Neurofibromatosis type-1 (NF1) is a common neurogenetic disorder and an important cause of intellectual disability. Brain-behaviour associations can be examined in vivo using morphometric magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) to study brain structure. Here, we studied structural and behavioural phenotypes in heterozygous Nf1 mice (Nf1(+/-) ) using T2-weighted imaging MRI and DTI, with a focus on social recognition deficits. We found that Nf1(+/-) mice have larger volumes than wild-type (WT) mice in regions of interest involved in social cognition, the prefrontal cortex (PFC) and the caudate-putamen (CPu). Higher diffusivity was found across a distributed network of cortical and subcortical brain regions, within and beyond these regions. Significant differences were observed for the social recognition test. Most importantly, significant structure-function correlations were identified concerning social recognition performance and PFC volumes in Nf1(+/-) mice. Analyses of spatial learning corroborated the previously known deficits in the mutant mice, as corroborated by platform crossings, training quadrant time and average proximity measures. Moreover, linear discriminant analysis of spatial performance identified 2 separate sub-groups in Nf1(+/-) mice. A significant correlation between quadrant time and CPu volumes was found specifically for the sub-group of Nf1(+/-) mice with lower spatial learning performance, suggesting additional evidence for reorganization of this region. We found strong evidence that social and spatial cognition deficits can be associated with PFC/CPu structural changes and reorganization in NF1.
© 2016 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  Brain; magnetic resonance imaging; mice; neurofibromatosis type-1; social cognition; spatial learning

Mesh:

Year:  2016        PMID: 27283753      PMCID: PMC5603718          DOI: 10.1111/gbb.12305

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  40 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes.

Authors:  D H Gutmann; Y L Wu; N M Hedrick; Y Zhu; A Guha; L F Parada
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

3.  Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1.

Authors:  E L Wignall; P D Griffiths; N G Papadakis; I D Wilkinson; L I Wallis; O Bandmann; P E E Cowell; N Hoggard
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

4.  Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.

Authors:  Carrie Shilyansky; Katherine H Karlsgodt; Damian M Cummings; Kyriaki Sidiropoulou; Molly Hardt; Alex S James; Dan Ehninger; Carrie E Bearden; Panayiota Poirazi; J David Jentsch; Tyrone D Cannon; Michael S Levine; Alcino J Silva
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

5.  Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Authors:  Karin S Walsh; Jorge I Vélez; Peter G Kardel; Daniel M Imas; Maximilian Muenke; Roger J Packer; Francisco X Castellanos; Maria T Acosta
Journal:  Dev Med Child Neurol       Date:  2012-11-16       Impact factor: 5.449

6.  Neuropsychological deficits in adults with neurofibromatosis type 1.

Authors:  M E Zöller; B Rembeck; L Bäckman
Journal:  Acta Neurol Scand       Date:  1997-04       Impact factor: 3.209

7.  Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1.

Authors:  L E Cutting; C W Koth; C P Burnette; M T Abrams; W E Kaufmann; M B Denckla
Journal:  J Child Neurol       Date:  2000-03       Impact factor: 1.987

8.  Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.

Authors:  T A Rizvi; S Akunuru; G de Courten-Myers; R C Switzer; M L Nordlund; N Ratner
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

9.  Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1.

Authors:  S L Zamboni; T Loenneker; E Boltshauser; E Martin; K A Il'yasov
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

10.  Alterations in white matter microstructure in neurofibromatosis-1.

Authors:  Katherine H Karlsgodt; Tena Rosser; Evan S Lutkenhoff; Tyrone D Cannon; Alcino Silva; Carrie E Bearden
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more
  5 in total

1.  Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.

Authors:  Susan E Maloney; Krystal C Chandler; Corina Anastasaki; Michael A Rieger; David H Gutmann; Joseph D Dougherty
Journal:  Autism Res       Date:  2017-08-26       Impact factor: 5.216

Review 2.  Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

Authors:  Juliana Magdalon; Sandra M Sánchez-Sánchez; Karina Griesi-Oliveira; Andréa L Sertié
Journal:  Int J Mol Sci       Date:  2017-03-18       Impact factor: 5.923

3.  Autism-associated Nf1 deficiency disrupts corticocortical and corticostriatal functional connectivity in human and mouse.

Authors:  Ben Shofty; Eyal Bergmann; Gil Zur; Jad Asleh; Noam Bosak; Alexandra Kavushansky; F Xavier Castellanos; Liat Ben-Sira; Roger J Packer; Gilbert L Vezina; Shlomi Constantini; Maria T Acosta; Itamar Kahn
Journal:  Neurobiol Dis       Date:  2019-05-22       Impact factor: 5.996

Review 4.  Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.

Authors:  Andrew H Miller; Mary C Halloran
Journal:  Dis Model Mech       Date:  2022-08-29       Impact factor: 5.732

5.  MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders.

Authors:  Sarah C Borrie; Ellen Plasschaert; Zsuzsanna Callaerts-Vegh; Akihiko Yoshimura; Rudi D'Hooge; Ype Elgersma; Steven A Kushner; Eric Legius; Hilde Brems
Journal:  Mol Autism       Date:  2021-07-26       Impact factor: 7.509

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.